Crossref

1. Repurposing antiviral drugs against HTLV-1 protease by molecular docking and molecular dynamics simulation

- Hamidreza Jahantigh

- Nahid Ahmadi

- Piero Lovreglio

- Angela Stufano

- Maryam Enayatkhani

- Behzad Shahbazi

- Khadijeh Ahmadi

2. Dysregulation of immune gene expression profiles during HTLV-1 infection

- Masoud Keikha

- Mohammad Ali-Hassanzadeh

- Ramin Bagheri

- Mohsen Karbalaei

3.

4. Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities

- Shivam Chowdhary

- Rahul Deka

- Kingshuk Panda

- Rohit Kumar

- Abhishikt David Solomon

- Jimli Das

- Supriya Kanoujiya

- Ashish Kumar Gupta

- Somya Sinha

- Janne Ruokolainen

- Kavindra Kumar Kesari

- Piyush Kumar Gupta

5. New Perspectives about Drug Candidates Targeting HTLV-1 and Related Diseases

- Milena Cristina Martins da Silva

- Renan Stefferson Barradas Pereira

- Antonia Cherlly Aparecida Araujo

- Ednilson Gregorio da Silva Filho

- Anderson de Lima Dias

- Kassio Silva Cavalcante

- Maísa Silva de Sousa

6. Cloaked Viruses and Viral Factors in Cutting Edge Exosome-Based Therapies

- Christos Dogrammatzis

- Hope Waisner

- Maria Kalamvoki

7. Blockade of LIRs as a new approach for diagnostics and treatment of ATLL malignancy

- M. Keikha

- M. Karbalaei

8. Molecular targeting of PD-1 signaling pathway as a novel therapeutic approach in HTLV-1 infection

- Masoud Keikha

- Kiarash Ghazvini

- Majid Eslami

- Bahman Yousefi

- Jorge Casseb

- Masoud Yousefi

- Mohsen Karbalaei

9.